Published 17 days ago

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

Summary by News Medical

0 Articles

All

Left

Center

Right

Medical Xpress

Experimental malaria monoclonal antibody protective in Malian children

One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children in Mali during the country's six-month malaria season, according to the results of a mid-stage clinical trial. The trial assessed an investigational monoclonal antibody developed by scientists at the National Institutes of Health (NIH), and results appear in The New England Journal of Medicine.

17 days ago

Read Full Article

News Medical

Single dose of malaria monoclonal antibody 77% effective in children, trial in Mali shows

16 days ago·United States

Read Full Article

Sci Tech Daily

Experimental NIH Antibody Protects Children From Malaria in Clinical Trial

A new study reports a single dose of a malaria antibody was 77% effective in protecting children in Mali from malaria, marking a significant step in malaria prevention efforts. One injected dose of an experimental malaria monoclonal antibody was 77% effective against malaria disease in children i

17 days ago

Read Full Article